Amoxicillin Patent Expiration
Amoxicillin is Used for treating tonsillitis and/or pharyngitis caused by Streptococcus pyogenes with once-a-day amoxicillin product. It was first introduced by Glaxosmithkline
Amoxicillin Patents
Given below is the list of patents protecting Amoxicillin, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Moxatag | US8299052 | Pharmaceutical compositions and methods for improved bacterial eradication | May 07, 2027 | Pragma |
Moxatag | US8357394 | Compositions and methods for improved efficacy of penicillin-type antibiotics | Dec 08, 2026 | Pragma |
Moxatag | US8778924 | Modified release amoxicillin products | Dec 08, 2026 | Pragma |
Moxatag | US6544555 | Antibiotic product, use and formulation thereof |
Oct 13, 2020
(Expired) | Pragma |
Moxatag | US6669948 | Antibiotic product, use and formulation thereof |
Oct 13, 2020
(Expired) | Pragma |
Moxatag | US6723341 | Antibiotic product, use and formulation thereof |
Oct 13, 2020
(Expired) | Pragma |
Amoxicillin's Family Patents
Explore Our Curated Drug Screens
Amoxicillin Generic API Manufacturers
Several generic applications have been filed for Amoxicillin. The first generic version for Amoxicillin was by Apothecon Inc Div Bristol Myers Squibb and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Micro Labs Ltd and was approved on Jun 24, 2022.
Given below is the list of companies who have filed for Amoxicillin generic, along with the locations of their manufacturing plants worldwide.
1. APOTHECON
Apothecon Inc Div Bristol Myers Squibb has filed for 6 different strengths of generic version for Amoxicillin. Out of these 125mg/5ml version comes by the name TRIMOX, 250mg/5ml version comes by the name TRIMOX, 500mg version comes by the name TRIMOX, 50mg/ml version comes by the name TRIMOX. Given below are the details of the strengths of this generic introduced by Apothecon.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
125MG/5ML | for suspension | Discontinued | ORAL | N/A | Mar 8, 1988 |
250MG/5ML | for suspension | Discontinued | ORAL | N/A | Mar 8, 1988 |
250MG | tablet, chewable | Discontinued | ORAL | N/A | May 6, 1996 |
500MG | capsule | Discontinued | ORAL | N/A | Mar 20, 1992 |
50MG/ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
125MG | tablet, chewable | Discontinued | ORAL | N/A | May 6, 1996 |
Manufacturing Plant Locations New
Apothecon's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Apothecon as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
2. AUROBINDO
Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Aurobindo.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
875MG | tablet | Prescription | ORAL | AB | Nov 9, 2005 |
500MG | capsule | Prescription | ORAL | AB | Nov 9, 2005 |
250MG | capsule | Prescription | ORAL | AB | Nov 9, 2005 |
200MG/5ML | for suspension | Prescription | ORAL | AB | Dec 28, 2006 |
400MG/5ML | for suspension | Prescription | ORAL | AB | Dec 28, 2006 |
Manufacturing Plant Locations New
Aurobindo's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||
United States |
|
3. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG | tablet, for suspension | Discontinued | ORAL | N/A | Jan 17, 2007 |
400MG | tablet, for suspension | Discontinued | ORAL | N/A | Jan 17, 2007 |
125MG/5ML | for suspension | Prescription | ORAL | AB | Sep 15, 2014 |
250MG/5ML | for suspension | Prescription | ORAL | AB | Sep 15, 2014 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
4. CHARTWELL
Chartwell Life Molecules Llc has filed for 2 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Chartwell.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | capsule | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
500MG | capsule | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
Manufacturing Plant Locations New
Chartwell's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Chartwell as present at those locations.
Country | City | Firm Name | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
|
5. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 6 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
125MG/5ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
250MG/5ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
125MG | tablet, chewable | Discontinued | ORAL | N/A | Jan 29, 1996 |
250MG | tablet, chewable | Discontinued | ORAL | N/A | Jan 29, 1996 |
400MG/5ML | for suspension | Prescription | ORAL | AB | Jun 18, 2007 |
875MG | tablet | Discontinued | ORAL | N/A | Jan 15, 2009 |
6. ENDO OPERATIONS
Endo Operations Ltd has filed for 2 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Endo Operations.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG/5ML | for suspension | Discontinued | ORAL | N/A | Nov 25, 1988 |
125MG/5ML | for suspension | Discontinued | ORAL | N/A | Nov 25, 1988 |
7. HIKMA
Hikma Pharmaceuticals Llc has filed for 7 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
875MG | tablet | Prescription | ORAL | AB | Mar 29, 2006 |
400MG/5ML | for suspension | Prescription | ORAL | AB | Jun 19, 2006 |
125MG/5ML | for suspension | Prescription | ORAL | AB | Jun 19, 2006 |
200MG/5ML | for suspension | Prescription | ORAL | AB | Jun 19, 2006 |
250MG/5ML | for suspension | Prescription | ORAL | AB | Jun 19, 2006 |
125MG | tablet, chewable | Discontinued | ORAL | N/A | Jun 25, 2020 |
250MG | tablet, chewable | Discontinued | ORAL | N/A | Jun 25, 2020 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
Portugal |
| |||||||||
Jordan |
|
8. HIKMA PHARMS
Hikma Pharmaceuticals has filed for 2 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Hikma Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
500MG | capsule | Prescription | ORAL | AB | Feb 5, 2007 |
250MG | capsule | Prescription | ORAL | AB | Feb 5, 2007 |
9. LABS ATRAL
Laboratorios Atral Sarl has filed for 2 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Labs Atral.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | capsule | Discontinued | ORAL | N/A | Aug 7, 1985 |
500MG | capsule | Discontinued | ORAL | N/A | Aug 7, 1985 |
10. MICRO LABS
Micro Labs Ltd has filed for 2 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Micro Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | capsule | Prescription | ORAL | AB | Jun 24, 2022 |
500MG | capsule | Prescription | ORAL | AB | Jun 24, 2022 |
Manufacturing Plant Locations New
Micro Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Micro Labs as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
India |
|
11. MYLAN
Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Mylan.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | capsule | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
500MG | capsule | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
125MG/5ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
250MG/5ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
Country | City | Firm Name | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||
India |
| |||||||||||||||||
Canada |
| |||||||||||||||||
Ireland |
|
12. PARKE DAVIS
Parke Davis Div Warner Lambert Co has filed for 4 different strengths of generic version for Amoxicillin. All of these versions come by the name UTIMOX. Given below are the details of the strengths of this generic introduced by Parke Davis.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | capsule | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
500MG | capsule | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
125MG/5ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
250MG/5ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
13. RANBAXY LABS LTD
Ranbaxy Laboratories Ltd has filed for 3 different strengths of generic version for Amoxicillin. All of these versions come by the name DISPERMOX. Given below are the details of the strengths of this generic introduced by Ranbaxy Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
400MG | tablet, for suspension | Discontinued | ORAL | N/A | Aug 11, 2003 |
200MG | tablet, for suspension | Discontinued | ORAL | N/A | Aug 11, 2003 |
600MG | tablet, for suspension | Discontinued | ORAL | N/A | Dec 4, 2003 |
14. SANDOZ
Sandoz Inc has filed for 7 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | capsule | Prescription | ORAL | AB | Sep 30, 1994 |
500MG | tablet | Prescription | ORAL | AB | Jul 13, 2005 |
875MG | tablet | Prescription | ORAL | AB | Jul 13, 2005 |
125MG/5ML | for suspension | Prescription | ORAL | AB | Mar 26, 2007 |
400MG/5ML | for suspension | Prescription | ORAL | AB | Mar 26, 2007 |
250MG/5ML | for suspension | Prescription | ORAL | AB | Mar 26, 2007 |
200MG/5ML | for suspension | Prescription | ORAL | AB | Mar 26, 2007 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
Austria |
| |||||
United States |
| |||||
Spain |
| |||||
India |
|
15. STRIDES PHARMA
Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Strides Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | capsule | Discontinued | ORAL | N/A | Feb 25, 1988 |
500MG | capsule | Discontinued | ORAL | N/A | Feb 25, 1988 |
Manufacturing Plant Locations New
Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
| |||||
India |
|
16. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 8 different strengths of generic version for Amoxicillin. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | tablet, chewable | Discontinued | ORAL | N/A | Dec 23, 1999 |
500MG | tablet | Discontinued | ORAL | N/A | Nov 24, 2000 |
125MG | tablet, chewable | Discontinued | ORAL | N/A | Dec 23, 1999 |
875MG | tablet | Discontinued | ORAL | N/A | Nov 24, 2000 |
200MG | tablet, chewable | Discontinued | ORAL | N/A | Nov 29, 2000 |
400MG | tablet, chewable | Discontinued | ORAL | N/A | Nov 29, 2000 |
200MG/5ML | for suspension | Discontinued | ORAL | N/A | Nov 29, 2002 |
400MG/5ML | for suspension | Discontinued | ORAL | N/A | Nov 29, 2002 |
17. TEVA
Teva Pharmaceuticals Usa Inc has filed for 9 different strengths of generic version for Amoxicillin. Out of these 50mg/ml version comes by the name AMOXICILLIN PEDIATRIC. Given below are the details of the strengths of this generic introduced by Teva.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | tablet, chewable | Discontinued | ORAL | N/A | Dec 19, 1996 |
500MG | tablet | Prescription | ORAL | AB | Sep 18, 2000 |
125MG/5ML | for suspension | Discontinued | ORAL | N/A | Nov 1, 1988 |
250MG/5ML | for suspension | Discontinued | ORAL | N/A | Jan 6, 1989 |
50MG/ML | for suspension | Prescription | ORAL | AB | Dec 1, 1982 |
125MG | tablet, chewable | Discontinued | ORAL | N/A | Dec 19, 1996 |
875MG
(reference standard) | tablet | Prescription | ORAL | AB | Sep 18, 2000 |
200MG/5ML | for suspension | Prescription | ORAL | AB | Dec 4, 2002 |
400MG/5ML
(reference standard) | for suspension | Prescription | ORAL | AB | Dec 4, 2002 |
Manufacturing Plant Locations New
Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
India |
| |||||||||
Canada |
| |||||||||
Czech Republic |
| |||||||||
Ireland |
| |||||||||
Israel |
|
18. US ANTIBIOTICS
Us Antibiotics Llc has filed for 5 different strengths of generic version for Amoxicillin. Out of these 500mg version comes by the name AMOXIL, 125mg/5ml version comes by the name LAROTID, 250mg/5ml version comes by the name LAROTID, 50mg/ml version comes by the name AMOXIL, 250mg version comes by the name AMOXIL. Given below are the details of the strengths of this generic introduced by Us Antibiotics.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
500MG | capsule | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
125MG/5ML | for suspension | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
250MG/5ML | for suspension | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
50MG/ML | for suspension | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
250MG | capsule | Prescription | ORAL | AB | Approved Prior to Jan 1, 1982 |
19. WYETH AYERST
Wyeth Ayerst Laboratories has filed for 4 different strengths of generic version for Amoxicillin. All of these versions come by the name WYMOX. Given below are the details of the strengths of this generic introduced by Wyeth Ayerst.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
250MG | capsule | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
500MG | capsule | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
125MG/5ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |
250MG/5ML | for suspension | Discontinued | ORAL | N/A | Approved Prior to Jan 1, 1982 |